Form D — OrbiMed Genesis Fund, L.P.
0000902664-25-005202 · filed 2025-12-05
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.7
- Total offering
- —
- Total sold
- $353,340,923
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- OrbiMed Genesis Fund, L.P.
- CIK
- 1796304
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- C/O ORBIMED GENESIS GP LLC
NEW YORK, NY 10022 - Phone
- (212) 739-6400
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
- OrbiMed Genesis GP LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
- OrbiMed Advisors LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Sven H. Borho · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Carl L. Gordon · Executive OfficerNew York, NY Find on LinkedIn ↗
-
W. Carter Neild · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Geoffrey C. Hsu · Executive OfficerNew York, NY Find on LinkedIn ↗
-
C. Scotland Stevens · Executive OfficerNew York, NY Find on LinkedIn ↗
-
David P. Bonita · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Matthew S. Rizzo · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Peter A. Thompson · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Mona Ashiya · Executive OfficerNew York, NY Find on LinkedIn ↗
View original on SEC EDGAR.